Company news

Q32 Bio Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Homology Medicines Reports Second Quarter 2020 Financial Results and Provides Business Update

August 9, 2020

Homology Medicines Appoints Jeff Poulton to the Board of Directors

July 20, 2020

Homology Medicines Announces Peer-Reviewed Publication Describing Molecular Characterization of Precise In Vivo Nuclease-Free Gene Editing with PKU Program

May 25, 2020

Homology Medicines Announces Presentations on its In Vivo Gene Therapy and Gene Editing Programs and Commercial Manufacturing Platform at the American Society of Gene & Cell Therapy Annual Meeting

May 11, 2020

Homology Medicines Reports First Quarter 2020 Financial Results and Recent Highlights

May 6, 2020

Homology Medicines Announces Presentations at Upcoming American Society for Gene & Cell Therapy Annual Meeting

April 28, 2020

Homology Medicines Announces Peer-Reviewed Publication of HMI-102 Investigational Gene Therapy Demonstrating Restoration of Normal Metabolic Pathway in PKU Disease Model

March 15, 2020

← Newer news releases

Decks

The 5 newest of 7 decks. Every deck is listed under its year.